CASI Pharma (CASI) Misses Q3 EPS by 67c

CASI Pharma (NASDAQ: CASI) reported Q3 EPS of ($0.67). Revenue for the quarter came in at $3.07 million.

For earnings history and earnings-related data on CASI Pharma (CASI) click here.

You May Also Be Interested In

• B.Riley on AMC Entertainment (AMC) earnings: 'Overall, we thought this was an encouraging report'
• Evercore ISI on Apple (AAPL) DoJ Report Amid 2.67% Drop: 'We view the report as a modest positive'
• Jefferies Reiterates Buy Rating on NewAmsterdam Pharma Co NV (NAMS)